Price target
6.200.000.00%
The 5 analysts offering 1 year price forecasts for 0R1D have a max estimate of — and a min estimate of —.
Analyst rating
Based on 7 analysts giving stock ratings to 0R1D in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
0R1D EPS for the last quarter is 0.04 USD despite the estimation of −0.02 USD. In the next quarter EPS is expected to reach −0.09 USD. Track more of SANGAMO THERAPEUTICS INC COM USD0.01 financials and stay on top of what is up with the company.
In the next quarter SANGAMO THERAPEUTICS INC COM USD0.01 revenue is expected to reach 10.38 M USD. Check out SANGAMO THERAPEUTICS INC COM USD0.01 revenue and earnings and make informed decisions.
According to analysts, 0R1D price target is 6.20 USD with a max estimate of 10.00 USD and a min estimate of 2.00 USD. Check if this forecast comes true in a year, meanwhile watch SANGAMO THERAPEUTICS INC COM USD0.01 stock price chart and keep track of the current situation with 0R1D news and stock market news.
We've gathered opinions of 7 analysts rating 0R1D stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.